Company: CCIXW
Filing Date: 2025-12-05
Form Type: S-4/A
Source: 0001193125-25-309933
Chunk: 134

Company: Churchill Capital Corp IX/Cayman
Filing Date: 2025-12-05
Form: S-4/A
Chunk 134
---
 associated with our software-focused business model may not be sufficient to offset the value-sharing associated with our OEM partnerships or may cause our approach to be less profitable than vertically-integrated business models.

Moreover, autonomous driving technology is a new offering, and the appropriate price points and pricing models are as yet undetermined. While we believe that our Driver-as-a-Service (“DaaS”) model will be attractive to fleet operators, the DaaS model is unproven and may fail to gain commercial acceptance. Going forward, we expect the volume of committed DaaS contracts to be an important indicator of our future performance, and we currently have no binding commitments from fleet operators to enter into DaaS agreements. As more market participants achieve sufficient safety and autonomy to begin commercialization, increased competition may result in pricing pressure and reduced margins and may impede our ability to increase revenue or cause us to lose market share, any of which could materially and adversely affect our business, financial condition, and results of operations. Unfavorable changes in any of these or other factors, many of which are beyond our control, could materially and adversely affect our business, prospects, financial condition and results of operations.

Deployment and commercialization may be delayed due to delays in our anticipated timeline for completion and validation of acceptable safety testing and measures for our technology and the development of plans for ensuring acceptable driver-out safety, delays in the production, reliability or revision of truck and computer hardware required for our technology from our partners or suppliers.

We do not currently have active deployments for SuperDrive and there can be no guarantee that deployments will be achieved. Deployment and commercialization of our technology requires that we meet exacting standards for safety and reliability, which may be delayed. Until we have completed and validated acceptable safety testing and measures for our technology, the commercial applications of our technology will be limited, and our OEM partners’ deployment of our technology may be delayed. If our technology fails to perform as intended or its development takes longer than currently projected, our commercial competitiveness, prospects, business, financial condition and results of operations may be adversely affected.

Once validated, deployment and commercialization of our technology will also depend on our OEM partners’ manufacture and distribution of autonomous vehicles that utilize our technology. This could be subject to delays or challenges experienced by our OEM partners in integrating our technology, changes in their designs, or challenges in production of autonomous vehicles that utilize our technology, including due to potential disruption to our OEM partners’ supply chains. If our OEM partners’ deployment of our technology is subject to unforeseen delays, our commercial